NCT04224571
- Conditions
- Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Hong Kong Children's Hospital Hong Kong
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,020 public trials
2,031 recruiting studies
Immunoproliferative Disorders trial results
NCT02962401
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Project manager Tours, France
NCT03144583
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Hospital Clínic of Barcelona Barcelona, Spain
- Hospital Sant Joan de Deu Barcelona, Spain
NCT02597062
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada
- QEII Health Sciences Centre Halifax, Nova Scotia, Canada
- Kingston Health Sciences Centre Kingston, Ontario, Canada
NCT06012383
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
NCT04187248
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Aarhus University Hospital, Department of Pediatrics Skejby Hospital Aarhus, Aarhus N, Denmark
NCT00078949
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
- Locations
-
- Rush-Presbyterian-St. Luke's Medical Centre Chicago, Illinois, United States
- Indiana University Medical Center Indianapolis, Indiana, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- University of Cincinnati, Barrett Cancer Centre Cincinnati, Ohio, United States
Completed
Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma
NCT00168727
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Loma Linda University Loma Linda, California, United States
- North County Oncology Oceanside, California, United States
- Medical Specialists of Fairfield Fairfield, Connecticut, United States
- Queens Hospital Honolulu, Hawaii, United States
NCT03260855
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Institut Universitaire du Cancer de Toulouse CHU de Toulouse Toulouse, France
NCT03128164
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- TongJi Medical College Huazhong University of Science& Technology Wuhan, Hubei, China
- Sun Yat-sen University cancer center Guangzhou, China
- Fudan University Shanghai Cancer Center Shanghai, China